Structure and dynamics of macrophage infectivity potentiator proteins from pathogenic bacteria and protozoans bound to fluorinated pipecolic acid inhibitors

24 May 2024, Version 1

Abstract

Macrophage infectivity potentiator (MIP) proteins are present in many microbial pathogens, both of pro- and of eukaryotic origin. MIP proteins play important roles in microbial virulence, facilitating processes like host cell infection, pathogen replication and dissemination. While their domain architecture differs in MIPs, they all share a FKBP (FK506 binding protein)-like prolyl-cis/trans-isomerase domain. Due to its high conservation, the FKBP domain has been a target for inhibitor development, including pipecolic acid derivatives. Here, we determined the high-resolution crystal structures of Burkholderia pseudomallei and Trypanosoma cruzi MIP in complex with fluorinated pipecolic acid inhibitors. Furthermore, we compared the inhibitor binding profiles of MIP proteins from B. pseudomallei, T. cruzi and Legionella pneumophila MIP using 1H, 15N-NMR spectroscopy. Additionally, 19F NMR was used to gauge inhibitor binding to the different MIP proteins. Complementary approaches including EPR spectroscopy and SAXS were used to investigate the global structural changes of homodimeric L. pneumophila MIP upon inhibitor binding. Our data provide a foundation for future inhibitor optimization and advance our understanding of the unexpected dynamic variability within a structurally conserved protein family.

Keywords

Macrophage infectivity potentiator (MIP)
virulence factor
Protein dynamics
Melioidosis
Legionnaire’s disease
Chagas fever

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Supporting Information for Pérez Carrillo et al.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.